VCYT Insider Trading Activity and SEC Form 4 Filings
Trump's trades in VCYT
From his financial disclosures
-
0 purchases
$15K+
1 sale
Sale
Jul 29, 2026
Reported 55d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
VCYT insider trading summary
Over the past 12 months, insiders at Veracyte, Inc. (VCYT) reported 52 sales worth $19.7M by 11 insiders and no open-market purchases on SEC Form 4. Net insider selling was $19.7M.
Latest VCYT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 27, 2026 | Karin Eastham | Director | Sell | $743K (14,850 @ $50.00) |
| Oct 27, 2026 | Jens Holstein | Director | Sell | $375K (7,500 @ $50.00) |
| Oct 19, 2026 | Muna Bhanji | Director | Sell | $81K (1,864 @ $43.70) |
| Sep 24, 2026 | Jens Holstein | Director | Sell | $353K (7,500 @ $47.00) |
| Sep 21, 2026 | John Leite | Global Chief Commercial Off | Sell | $161K (4,015 @ $40.00) |
| Sep 14, 2026 | Jens Holstein | Director | Sell | $205K (5,000 @ $40.95) |
| Sep 4, 2026 | Phillip G. Febbo | Chief Scientific & Med Officer | Sell | $118K (2,705 @ $43.66) |
| Sep 4, 2026 | Phillip G. Febbo | Chief Scientific & Med Officer | Sell | $446K (10,405 @ $42.89) |
| Sep 4, 2026 | Rebecca Chambers | Chief Financial Officer | Sell | $106K (2,477 @ $42.81) |
| Sep 4, 2026 | Annie McGuire | EVP, General Counsel | Sell | $92K (2,154 @ $42.79) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.